Rezultati pretrage - Cihui Yan
- Prikaz rezultata 1 – 11 od 11
-
1
-
2
-
3
Induction of PD-L1 expression by epidermal growth factor receptor–mediated signaling in esophageal squamous cell carcinoma od Wencheng Zhang, Qingsong Pang, Cihui Yan, Qifeng Wang, Jingsong Yang, Shufei Yu, Xiao Liu, Zhiyong Yuan, Ping Wang, Zefen Xiao
Izdano 2017Artigo -
4
Tumor regression after combination of radiation and PD-1 antibody nivolumab treatment in a patient with metastatic mediastinal leiomyosarcoma: a case report od Xi, Chen, Wencheng, Zhang, Dong, Qian, Yong, Guan, Cihui, Yan, Yuwen, Wang, Hualei, Zhang, Puchun, Er, Qingsong, Pang, Ping, Wang
Izdano 2018Tekst -
5
Programmed death-ligand 1 is prognostic factor in esophageal squamous cell carcinoma and is associated with epidermal growth factor receptor od Wencheng Zhang, Qingsong Pang, Xiaodong Zhang, Cihui Yan, Qifeng Wang, Jinsong Yang, Shufei Yu, Xiao Liu, Yi Pan, Zhiyong Yuan, Ping Wang, Zefen Xiao
Izdano 2017Artigo -
6
Single-cell profiling of immune cells after neoadjuvant pembrolizumab and chemotherapy in IIIA non-small cell lung cancer (NSCLC) od Zhenzhen Hui, Jiali Zhang, Yulin Ren, Xiaoling Li, Cihui Yan, Wenwen Yu, Tao Wang, Shanshan Xiao, Yulong Chen, Ran Zhang, Feng Wei, Jian You, Xiubao Ren
Izdano 2022Artigo -
7
Spatial Distribution and Predictive Significance of Dendritic Cells and Macrophages in Esophageal Cancer Treated With Combined Chemoradiotherapy and PD-1 Blockade od Xiaoxue Ma, Zhoubo Guo, Xiaoying Wei, Gang Zhao, Dong Han, Tian Zhang, Xi Chen, Fuliang Cao, Jie Dong, Lujun Zhao, Zhiyong Yuan, Ping Wang, Qingsong Pang, Cihui Yan, Wencheng Zhang
Izdano 2022Artigo -
8
Anti-CD47 Antibody As a Targeted Therapeutic Agent for Human Lung Cancer and Cancer Stem Cells od Liang Liu, Lin Zhang, Lin Yang, Hui Li, Runmei Li, Jinpu Yu, Lili Yang, Feng Wei, Cihui Yan, Qian Sun, Hua Zhao, Fan Yang, Hao Jin, Jian Wang, Shizhen Emily Wang, Xiubao Ren
Izdano 2017Artigo -
9
HDAC Inhibitors Enhance T-Cell Chemokine Expression and Augment Response to PD-1 Immunotherapy in Lung Adenocarcinoma od Hong Zheng, Weipeng Zhao, Cihui Yan, Crystina C. Watson, Michael T. Massengill, Mengyu Xie, Chris Massengill, David Noyes, Gary V. Martinez, Roha Afzal, Zhihua Chen, Xiubao Ren, Scott Antonia, Eric B. Haura, Brian Ruffell, Amer A. Beg
Izdano 2016Artigo -
10
Addition of camrelizumab to docetaxel, cisplatin, and radiation therapy in patients with locally advanced esophageal squamous cell carcinoma: a phase 1b study od Wencheng Zhang, Cihui Yan, Tian Zhang, Xi Chen, Jie Dong, Jingjing Zhao, Dong Han, Jun Wang, Gang Zhao, Fuliang Cao, Dejun Zhou, Hongjing Jiang, Peng Tang, Lujun Zhao, Zhiyong Yuan, Quanren Wang, Ping Wang, Qingsong Pang
Izdano 2021Artigo -
11
Safety and Feasibility of Radiotherapy Plus Camrelizumab for Locally Advanced Esophageal Squamous Cell Carcinoma od Wencheng Zhang, Cihui Yan, Xuan Gao, Xiaoxia Li, Fuliang Cao, Gang Zhao, Jingjing Zhao, Puchun Er, Tian Zhang, Xi Chen, Yuwen Wang, Yao Jiang, Quanren Wang, Baozhong Zhang, Dong Qian, Jun Wang, Dejun Zhou, Xiubao Ren, Zhentao Yu, Lujun Zhao, Zhiyong Yuan, Ping Wang, Qingsong Pang
Izdano 2021Artigo
Alati za pretragu:
Povezani predmeti
Internal medicine
Medicine
Cancer research
Biology
Cancer
Immunology
Immune system
Immunotherapy
Oncology
Biochemistry
Cancer cell
Cell biology
Chemotherapy
Receptor
Chemistry
Chemoradiotherapy
Clinical endpoint
Cytotoxic T cell
Epidermal growth factor
Epidermal growth factor receptor
In vitro
Lung cancer
PD-L1
Pathology
Radiation therapy
Signal transduction
Surgery
Adenocarcinoma
Adverse effect
Antibody